Moo-Seung Lee Selected Research

Shiga Toxins (Vero Toxin)

11/2022	Inhibition of O-GlcNAcylation protects from Shiga toxin-mediated cell injury and lethality in host.
11/2020	Exosomes released from Shiga toxin 2a-treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells.
1/2020	Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs.
10/2017	Shiga Toxins Induce Apoptosis and ER Stress in Human Retinal Pigment Epithelial Cells.
3/2016	Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic Applications.
2/2016	Shiga Toxins Trigger the Secretion of Lysyl-tRNA Synthetase to Enhance Proinflammatory Responses.
4/2013	Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.
1/2010	Shiga toxins: intracellular trafficking to the ER leading to activation of host cell stress responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moo-Seung Lee Research Topics

Disease

8	Hemolytic-Uremic Syndrome 11/2022 - 04/2013
6	Infections 01/2020 - 12/2013
5	Neoplasms (Cancer) 12/2021 - 01/2016
4	Acute Kidney Injury (Acute Renal Failure) 11/2022 - 01/2010
4	Inflammation (Inflammations) 03/2021 - 04/2013
3	Colitis 11/2022 - 03/2016
2	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2021
2	Human Influenza (Influenza) 01/2022 - 10/2018
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Necrosis 01/2016 - 02/2015
1	Asthma (Bronchial Asthma) 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Leukemia 12/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Diarrhea 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Sepsis (Septicemia) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Typhoid Fever (Typhoid) 01/2018
1	Insulin Resistance 12/2017
1	Obesity 12/2017
1	Blindness (Hysterical Blindness) 10/2017
1	Gout 02/2015
1	Intestinal Diseases (Diseases, Intestinal) 01/2010

Drug/Important Bio-Agent (IBA)

8	Shiga Toxins (Vero Toxin)IBA 11/2022 - 01/2010
7	Virulence Factors (Pathogenicity Factors)IBA 11/2022 - 01/2010
5	CytokinesIBA 11/2020 - 12/2013
4	Shiga Toxin (Shigella Toxin)IBA 09/2018 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2018
3	ChemokinesIBA 01/2020 - 04/2013
2	Biological ProductsIBA 01/2022 - 03/2021
2	ProdigiosinIBA 12/2021 - 03/2021
1	PropionatesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Viral ProteinsIBA 01/2022
1	TrypsinIBA 01/2022
1	InterleukinsIBA 01/2022
1	SmokeIBA 01/2022
1	Ethanol (Ethyl Alcohol)IBA 12/2021
1	Histone-Lysine N-MethyltransferaseIBA 11/2021
1	Histone MethyltransferasesIBA 11/2021
1	src-Family KinasesIBA 01/2021
1	Retinal Pigments (Pigments, Visual)IBA 11/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Ribosome Inactivating ProteinsIBA 01/2020
1	VimentinIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Plant ProteinsIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Lipid AIBA 01/2019
1	LigandsIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	AntigensIBA 10/2018
1	NucleoproteinsIBA 10/2018
1	Antiviral Agents (Antivirals)IBA 10/2018
1	ginsenoside Rg3IBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	Therapeutic UsesIBA 12/2017
1	NucleotidesIBA 01/2017
1	InflammasomesIBA 02/2015
1	Interleukin-18 (Interleukin 18)IBA 02/2015
1	Interleukin-8 (Interleukin 8)IBA 04/2013
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 04/2013
1	Biomarkers (Surrogate Marker)IBA 04/2013
1	Messenger RNA (mRNA)IBA 04/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2013
1	Drinking WaterIBA 01/2010

Therapy/Procedure

1	Bioreactors (Bioreactor) 12/2021
1	Therapeutics 01/2021
1	Intranasal Administration 01/2020
1	Ligation 01/2019
1	Punctures 01/2019